Carl L. Gordon - Insider Trading & Ownership

Entity
Individual
Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Summary
The estimated net worth of Carl L. Gordon is at least $30M dollars as of November 5, 2024. Carl L. Gordon is the Director of Venetian-1 Acquisition Corp. and owns shares of Venetian-1 Acquisition Corp. stock worth about $10.7M. Carl L. Gordon is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. Carl L. Gordon is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. Carl L. Gordon is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $5.26M. Carl L. Gordon is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $942K.
All Insider Reports
All Insider Reports

Ownership of Carl L. Gordon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NONE Venetian-1 Acquisition Corp. Director $10.7M Nov 1, 2024
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $7.56M -$562K -6.92% Jul 15, 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner $5.52M Jan 30, 2024
KROS Keros Therapeutics, Inc. Director $5.26M -$11M -67.7% Aug 13, 2024
ACET Adicet Bio, Inc. Director, 10%+ Owner $942K Aug 21, 2024
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 Apr 3, 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 Feb 14, 2024
CMPX Compass Therapeutics, Inc. Director, 10%+ Owner Feb 9, 2024
IRON Disc Medicine, Inc. Director, 10%+ Owner Oct 4, 2021
MBX MBX Biosciences, Inc. Director, 10%+ Owner Sep 16, 2024
ORIC Oric Pharmaceuticals, Inc. Director, 10%+ Owner Jun 16, 2021

Insider Transactions Reported by Carl L. Gordon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.